UFT 100 mg/224 mg CAPSULAS DURAS España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

uft 100 mg/224 mg capsulas duras

merck, s.l. - tegafur, uracilo - excipientes: laurilsulfato de sodio - antimetabolitos - análogos de las pirimidinas - tegafur, combinaciones con

UTEFOS  400 mg CAPSULAS DURAS España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

utefos 400 mg capsulas duras

mylan pharmaceuticals, s.l. - tegafur - cÁpsula dura - 400 mg - tegafur 400 mg - tegafur

Teysuno Unión Europea - español - EMA (European Medicines Agency)

teysuno

nordic group b.v. - tegafur, gimeracil, oteracil - neoplasmas estomacales - agentes antineoplásicos - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.

ASOFURTAL 100 mg -224 mg COMPRIMIDOS RECUBIERTOS Venezuela - español - Instituto Nacional de Higiene

asofurtal 100 mg -224 mg comprimidos recubiertos

representaciones nolver c.a. - tegafur -uracilo - comprimido recubierto - 100 mg-224 mg